NO20030139L - Farmasöytiske preparater inneholdende DDS forbindelser - Google Patents
Farmasöytiske preparater inneholdende DDS forbindelserInfo
- Publication number
- NO20030139L NO20030139L NO20030139A NO20030139A NO20030139L NO 20030139 L NO20030139 L NO 20030139L NO 20030139 A NO20030139 A NO 20030139A NO 20030139 A NO20030139 A NO 20030139A NO 20030139 L NO20030139 L NO 20030139L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparations
- preparations containing
- dds compounds
- containing dds
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000213083 | 2000-07-13 | ||
PCT/JP2001/006020 WO2002005855A1 (fr) | 2000-07-13 | 2001-07-11 | Compositions pharmaceutiques contenant des composes dds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030139D0 NO20030139D0 (no) | 2003-01-10 |
NO20030139L true NO20030139L (no) | 2003-03-13 |
Family
ID=18708899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030139A NO20030139L (no) | 2000-07-13 | 2003-01-10 | Farmasöytiske preparater inneholdende DDS forbindelser |
Country Status (12)
Country | Link |
---|---|
US (1) | US6815435B2 (es) |
EP (1) | EP1308171A1 (es) |
KR (1) | KR20030023697A (es) |
CN (1) | CN1556712A (es) |
AR (1) | AR031714A1 (es) |
AU (1) | AU2001271037A1 (es) |
BR (1) | BR0112417A (es) |
CA (1) | CA2415922A1 (es) |
MX (1) | MXPA03000387A (es) |
NO (1) | NO20030139L (es) |
RU (1) | RU2003100532A (es) |
WO (1) | WO2002005855A1 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002000734A1 (fr) * | 2000-06-29 | 2002-01-03 | Daiichi Pharmaceutical Co., Ltd. | Compose dds et son procede de preparation |
TWI320713B (es) * | 2001-06-01 | 2010-02-21 | Neochemir Inc | |
TW200306314A (en) * | 2002-04-16 | 2003-11-16 | Tanabe Seiyaku Co | Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation |
CN100366261C (zh) * | 2002-12-10 | 2008-02-06 | 田中雅也 | 皮肤外用材料及使用其的外用止痒剂和去皱用品 |
TW200727900A (en) * | 2005-07-27 | 2007-08-01 | Yakult Honsha Kk | Aqueous solution preparation containing camptothecins |
AU2013263795B2 (en) * | 2010-03-29 | 2015-09-17 | Ferring B.V. | A fast dissolving pharmaceutical composition |
JO3112B1 (ar) | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
ES2643087T3 (es) * | 2010-03-29 | 2017-11-21 | Ferring B.V. | Composición farmacéutica de disolución rápida |
CN103781467B (zh) | 2011-09-16 | 2016-08-31 | 辉凌公司 | 一种快速溶解药物组合物 |
BR122021014396B1 (pt) | 2012-10-11 | 2022-07-05 | Daiichi Sankyo Company, Limited | Compostos intermediários ligantes de fármacos, e ligante |
US9872924B2 (en) | 2012-10-19 | 2018-01-23 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
KR102535900B1 (ko) | 2013-12-25 | 2023-05-26 | 다이이찌 산쿄 가부시키가이샤 | 항 trop2 항체-약물 컨쥬게이트 |
BR112016013482B1 (pt) | 2014-01-31 | 2022-04-19 | Daiichi Sankyo Company, Limited | Conjugado de anticorpo anti-her2-fármaco, fármacos antitumor e/ou anticâncer e composição farmacêutica |
KR102445502B1 (ko) | 2014-04-10 | 2022-09-21 | 다이이찌 산쿄 가부시키가이샤 | 항her3 항체-약물 콘주게이트 |
ES2754348T3 (es) | 2014-04-10 | 2020-04-17 | Daiichi Sankyo Co Ltd | Conjugado de (anticuerpo anti-HER2)-fármaco |
AU2015369185B2 (en) | 2014-12-26 | 2020-10-22 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical preparation of camptothecin-containing polymer derivative |
IL290959B2 (en) | 2015-06-29 | 2023-04-01 | Daiichi Sankyo Co Ltd | Preparations containing antibody-drug conjugates and methods for their production |
JP6735759B2 (ja) | 2015-09-03 | 2020-08-05 | 日本化薬株式会社 | カンプトテシン類高分子誘導体を含有する医薬組成物 |
JP6797182B2 (ja) | 2016-03-01 | 2020-12-09 | 日本化薬株式会社 | カンプトテシン類高分子誘導体を含有する医薬製剤 |
US11273155B2 (en) | 2016-12-12 | 2022-03-15 | Daiichi Sankyo Company, Limited | Combination of antibody-drug conjugate and immune checkpoint inhibitor |
BR112019012847A2 (pt) | 2017-01-17 | 2019-12-10 | Daiichi Sankyo Co Ltd | anticorpo ou fragmento funcional do anticorpo, polinucleotídeo, vetor de expressão, células hospedeiras, método para produção de um anticorpo de interesse ou de um fragmento funcional do anticorpo e para produção de um conjugado de anticorpo-fármaco, conjugado de anticorpo-fármaco, composição farmacêutica, fármaco antitumoral, e, método de tratamento de um tumor. |
TWI794230B (zh) | 2017-05-15 | 2023-03-01 | 日商第一三共股份有限公司 | 抗cdh6抗體及抗cdh6抗體-藥物結合物、以及其製造方法 |
SG11202000997YA (en) | 2017-08-31 | 2020-03-30 | Daiichi Sankyo Co Ltd | Improved method for producing antibody-drug conjugate |
US11318212B2 (en) | 2017-08-31 | 2022-05-03 | Daiichi Sankyo Company, Limited | Method for producing antibody-drug conjugate |
CN112351999A (zh) | 2018-05-18 | 2021-02-09 | 第一三共株式会社 | 抗-muc1抗体-药物缀合物 |
TWI822822B (zh) | 2018-07-31 | 2023-11-21 | 日商第一三共股份有限公司 | 抗體-藥物結合物之用途 |
TW202116356A (zh) | 2019-07-10 | 2021-05-01 | 美商斯布雷克薩三號公司 | 作為治療劑之微管靶向藥劑之肽結合物 |
WO2021007435A1 (en) | 2019-07-10 | 2021-01-14 | Cybrexa 2, Inc. | Peptide conjugates of cytotoxins as therapeutics |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5711909A (en) * | 1980-06-23 | 1982-01-21 | Shionogi & Co Ltd | Stable freeze-dried preparation of beta-lactam |
JPS61165322A (ja) * | 1985-01-14 | 1986-07-26 | Microbial Chem Res Found | スパガリン類の注射用凍結乾燥製剤 |
EP0857484A4 (en) | 1995-09-13 | 2000-12-06 | Nippon Shinyaku Co Ltd | PGE1- FREEZING DRIED PREPARATION AND METHOD FOR THE PRODUCTION THEREOF |
PL328309A1 (en) * | 1996-02-19 | 1999-01-18 | Nycomed Imaging As | Thermally stabilised contrast medium |
AU2034097A (en) * | 1996-03-19 | 1997-10-10 | Morgan Crucible Company Plc, The | A conduit |
JPH10212241A (ja) | 1996-05-27 | 1998-08-11 | Sumitomo Pharmaceut Co Ltd | Bdnfを安定に含有する製剤 |
TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
US6583164B1 (en) | 1998-09-29 | 2003-06-24 | Takeda Chemical Industries, Ltd. | Antimycotic drug composition |
-
2001
- 2001-07-11 US US10/332,706 patent/US6815435B2/en not_active Expired - Fee Related
- 2001-07-11 MX MXPA03000387A patent/MXPA03000387A/es not_active Application Discontinuation
- 2001-07-11 RU RU2003100532/15A patent/RU2003100532A/ru not_active Application Discontinuation
- 2001-07-11 CA CA002415922A patent/CA2415922A1/en not_active Abandoned
- 2001-07-11 CN CNA018153607A patent/CN1556712A/zh active Pending
- 2001-07-11 AU AU2001271037A patent/AU2001271037A1/en not_active Abandoned
- 2001-07-11 EP EP01949945A patent/EP1308171A1/en not_active Withdrawn
- 2001-07-11 WO PCT/JP2001/006020 patent/WO2002005855A1/ja active Application Filing
- 2001-07-11 BR BR0112417-0A patent/BR0112417A/pt not_active Application Discontinuation
- 2001-07-11 KR KR10-2003-7000380A patent/KR20030023697A/ko not_active Application Discontinuation
- 2001-07-12 AR ARP010103302A patent/AR031714A1/es unknown
-
2003
- 2003-01-10 NO NO20030139A patent/NO20030139L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1308171A1 (en) | 2003-05-07 |
KR20030023697A (ko) | 2003-03-19 |
WO2002005855A1 (fr) | 2002-01-24 |
NO20030139D0 (no) | 2003-01-10 |
MXPA03000387A (es) | 2003-09-22 |
CA2415922A1 (en) | 2002-01-24 |
CN1556712A (zh) | 2004-12-22 |
AU2001271037A1 (en) | 2002-01-30 |
US6815435B2 (en) | 2004-11-09 |
US20030148931A1 (en) | 2003-08-07 |
AR031714A1 (es) | 2003-10-01 |
RU2003100532A (ru) | 2004-07-20 |
BR0112417A (pt) | 2003-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20030139D0 (no) | Farmasöytiske preparater inneholdende DDS forbindelser | |
NO20071303L (no) | Farmasoytiske preparater | |
NO20033556D0 (no) | Farmasöytiske preparater | |
IS5953A (is) | Lyfjablöndur úr örgerðum eplerenonum | |
NO20021401D0 (no) | Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser | |
ITTO20010008A0 (it) | Formulazione farmaceutica | |
EE200200038A (et) | Konservitud farmatseutilised preparaadid | |
NO20020464L (no) | Flerkomponents farmasöytisk doseringsform | |
NO20022970L (no) | Hydrogel-drevet medikamentdoseringsform | |
ATE238812T1 (de) | Voriconazol-enthaltende pharmazeutische zubereitungen | |
NO20030627L (no) | Hydrogel-drevet medikament doseringsform | |
AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
MXPA03001425A (es) | Compuestos farmaceuticos. | |
ATE332132T1 (de) | Verbesserte arzneizubereitungen enthaltend ritonavir | |
NO20026013D0 (no) | Medisinske preparater inneholdende propenonderivater | |
NO20014926D0 (no) | Farmasöytiske forbindelser | |
ATE324883T1 (de) | Pharmazeutische zusammensetzung enthaltend lumiracoxib | |
EE200300135A (et) | Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid | |
DE69926012D1 (de) | Arzneizubereitungen | |
PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
NO20016430L (no) | Farmasöytisk kompleks | |
AR025867A1 (es) | Formulacion portasdora farmaceutica | |
DE69906934D1 (de) | Arzneizubereitungen | |
FI20012242A0 (fi) | Uudet farmaseuttiset yhdisteet | |
DE50008261D1 (de) | Retardierte darreichungsform enthaltend tramadolsaccharinat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |